Literature DB >> 10872046

Correlation of bFGF, FGFR-1 and VEGF expression with vascularity and malignancy of human astrocytomas.

X W Bian1, L L Du, J Q Shi, Y S Cheng, F X Liu.   

Abstract

OBJECTIVE: To investigate the correlation of angiogenic factor expression levels with the degrees of malignancy and vascularity and their clinicopathologic significance in astrocytomas. STUDY
DESIGN: Factor VIII-related antigen (FVIII-RAg) was used as the marker of endothelia and basic fibroblast growth factor (bFGF); FGF receptor (FGFR)-1 and vascular endothelial growth factor (VEGF) were qualitatively and quantitatively detected with immunohistochemistry and image analysis in 61 brain astrocytomas. The correlation with tumor grades, angiogenesis and prognosis was studied.
RESULTS: Measurement of FVIIIRAg expression could describe endothelial proliferation and vascularity, which were related to grade of tumor and prognosis. bFGF and VEGF expression levels in neoplastic astrocytes and endothelia were significantly different in various grades of astrocytoma. These angiogenic factors affected the positive reaction areas and integral optical densities of FVIII-RAg as well as survival time. In contrast, the expression of FGFR-1 was related to neither bFGF nor FVIIIRAg and had no significant effect on tumor malignancy.
CONCLUSION: Positive regulation by bFGF and autocrine/paracrine VEGF contributes to the growth and angiogenesis of astrocytomas. Measurement of endothelial cell proliferation with FVIIIRAg in tumor stroma and quantitative detection of angiogenic factor levels in neoplastic cells had prognostic value in brain astrocytomas. The results also indicate that inhibiting bFGF and VEGF expression and/or blocking their effects could be a very useful therapeutic strategy for malignant gliomas.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10872046

Source DB:  PubMed          Journal:  Anal Quant Cytol Histol        ISSN: 0884-6812            Impact factor:   0.302


  23 in total

Review 1.  Beyond VEGF: inhibition of the fibroblast growth factor pathway and antiangiogenesis.

Authors:  Christopher Lieu; John Heymach; Michael Overman; Hai Tran; Scott Kopetz
Journal:  Clin Cancer Res       Date:  2011-09-27       Impact factor: 12.531

2.  Isolation and culture of microvascular endothelial cells from gliomas of different WHO grades.

Authors:  Sabine Miebach; Stefan Grau; Vera Hummel; Peter Rieckmann; Joerg-Christian Tonn; Roland Helmut Goldbrunner
Journal:  J Neurooncol       Date:  2006-01       Impact factor: 4.130

3.  Tumor microvascular architecture phenotype (T-MAP) as a new concept for studies of angiogenesis and oncology.

Authors:  Xiu-wu Bian; Qing-liang Wang; Hua-liang Xiao; Ji Ming Wang
Journal:  J Neurooncol       Date:  2006-05-16       Impact factor: 4.130

4.  S100A13, a new marker of angiogenesis in human astrocytic gliomas.

Authors:  M Landriscina; G Schinzari; G Di Leonardo; M Quirino; A Cassano; E D'Argento; L Lauriola; M Scerrati; I Prudovsky; C Barone
Journal:  J Neurooncol       Date:  2006-06-14       Impact factor: 4.130

5.  Basic fibroblast growth factor and fibroblast growth factor receptor-i in human meningiomas.

Authors:  Wei Yi; Jian Chen; Filimon H Golwa; Delin Xue
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

Review 6.  Anti-angiogenic therapy in pediatric neuro-oncology.

Authors:  Mark W Kieran
Journal:  J Neurooncol       Date:  2005-12       Impact factor: 4.130

7.  Adenovirus-mediated transfer of siRNA against basic fibroblast growth factor mRNA enhances the sensitivity of glioblastoma cells to chemotherapy.

Authors:  Xuequan Feng; Biao Zhang; Jinhuan Wang; Xinnv Xu; Na Lin; Hongsheng Liu
Journal:  Med Oncol       Date:  2010-02-24       Impact factor: 3.064

8.  Intratumoral hemorrhage-related differences in the expression of vascular endothelial growth factor, basic fibroblast growth factor and thioredoxin reductase 1 in human glioblastoma.

Authors:  Bulent Kaya; Onur Çiçek; Fatih Erdi; Siddika Findik; Yasar Karatas; Hasan Esen; Fatih Keskin; Erdal Kalkan
Journal:  Mol Clin Oncol       Date:  2016-08-02

9.  Comparison of microvascular permeability measurements, K(trans), determined with conventional steady-state T1-weighted and first-pass T2*-weighted MR imaging methods in gliomas and meningiomas.

Authors:  S Cha; L Yang; G Johnson; A Lai; M-H Chen; T Tihan; M Wendland; W P Dillon
Journal:  AJNR Am J Neuroradiol       Date:  2006-02       Impact factor: 3.825

10.  Overexpression of vascular endothelial growth factor indicates poor outcomes of glioma: a systematic review and meta-analysis.

Authors:  Wenjie Chen; Deshen He; Zuyun Li; Xin Zhang; Denghua Pan; Gang Chen
Journal:  Int J Clin Exp Med       Date:  2015-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.